Fernando Barcenilla

Learn More
INTRODUCTION Our aims were to assess risk factors, clinical features, management and outcomes in critically ill patients in whom Aspergillus spp. were isolated from respiratory secretions, using a database from a study designed to assess fungal infections. METHODS A multicentre prospective study was conducted over a 9-month period in 73 intensive care(More)
Ventilator-associated pneumonia (VAP) is a frequent cause of morbidity-mortality in critical patients, and is responsible for over 50% of the antibiotics (ATBs) used in the Intensive Care Unit (ICU). According to the Spanish National Surveillance Study on Nosocomial Infections in the ICU, associated to the Euro-pean project Hospitals in Europe Link for(More)
BACKGROUND Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season. The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted(More)
INTRODUCTION Despite the availability of new antibiotics such as daptomycin, methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia continues to be associated with high clinical failure rates. Combination therapy has been proposed as an alternative to improve outcomes but there is a lack of clinical studies. The study aims to demonstrate that(More)
  • 1